AI Science Tracker
EN

Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, People's Republic of China

1 discovery from 2026

Discoveries

Machine Learning-Based Prediction of 28-Day Mortality in Patients with Sepsis-Induced Cardiomyopathy: An Integrated Analysis of Inflammatory Biomarkers.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning models trained on 762 ICU patients with sepsis-induced cardiomyopathy predicted 28-day mortality; evaluation was internal and the authors call for multicenter external validation.

Technology: A machine-learning model predicts 28-day mortality in ICU patients with sepsis-induced cardiomyopathy.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A machine-learning model predicts 28-day mortality in ICU patients with sepsis-induced cardiomyopathy.
Test and result
Internal evaluation of 762 ICU patients; multicenter external validation is still needed.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.2147/jir.s628783 · https://pubmed.ncbi.nlm.nih.gov/42835371/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.